Since eotaxin is capable of crossing the blood–brain barrier, it is plausible that eotaxin can exert physiological and pathological actions in the central nervous system of ME/CFS patients. The gene discussed is CCL11; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.